Boston Scientific Recalls Lotus Edge Valve Systems Due to Deployment Defect
Boston Scientific is recalling 319 Lotus Edge Valve Systems because a visual inspection failure may prevent the delivery system from releasing during deployment.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class I, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death. Per the rubric, FDA Class I recalls are assigned a score of 4 or higher.
Plain-English summary
Boston Scientific Corporation is recalling 319 units of the Lotus Edge Valve System, a transcatheter aortic valve prosthesis premounted on a delivery system (25mm, sterile, REF H749LVSUS250). The recall affects all unexpired lot numbers with expiration dates ranging from November 2, 2020, to October 29, 2021.
The recall was initiated because a failure to correctly execute the visual inspection prior to locking the valve during the deployment process can lead to the inability to release the delivery system. This defect poses a risk to patients undergoing the procedure.
The devices were distributed to hospitals and government facilities in 37 U.S. states and the District of Columbia, as well as to 23 foreign countries including Australia, Canada, and several European nations. Healthcare providers should stop using these devices and contact Boston Scientific for instructions on return or replacement.
The recalled product
- Product
- Lotus Edge Valve System, Transcatheter Aortic Valve Prosthesis Premounted on Delivery System, 25mm, sterile, REF H749LVSUS250, GTIN 08714729960911, Made in Ireland, Ballybrit Business Park, Galway, Ireland.
- Manufacturer
- Boston Scientific Corporation
- Category
- Medical Device — Cardiovascular
- Affected units
- 319
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- GTIN 08714729960911
- All unexpired lot numbers
- expiration dates 2-Nov-2020 through 29-Oct-2021
Distribution
Part of a larger recall action
This product is one of 6 recalled by Boston Scientific Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Boston Scientific Corporation
See all →- HighBoston Scientific Recalls Suture Cinch Endoscopic Tissue Approximation Devices
FDA (Devices) · 2026-08-26
- HighBoston Scientific ENROUTE Transcarotid Neuroprotection System Plus Recall
FDA (Devices) · 2026-08-26
- HighBoston Scientific Recalls OverStitch Suture Cinch Devices for Deployment Failure
FDA (Devices) · 2026-08-26
- HighBoston Scientific ENROUTE Transcarotid Neuroprotection System Recall for Tip Separation
FDA (Devices) · 2026-08-26
- SevereRadial Jaw 4 Jumbo Biopsy Forceps Packaging Sterile Barrier Recall
FDA (Devices) · 2026-08-12
Same hazard · deployment failure
See all →- SevereGORE TAG Thoracic Branch Endoprosthesis Side Branch Component Recall
FDA (Devices) · 2026-07-08
- HighCGuard Prime 9mm by 30mm carotid stents may fail deployment
FDA (Devices) · 2026-06-17
- HighCGuard Prime 10mm by 30mm carotid stents may fail deployment
FDA (Devices) · 2026-06-17
- HighCGuard Prime 9mm carotid stent systems may resist or fail deployment
FDA (Devices) · 2026-06-17
- HighCGuard Prime 8mm by 30mm carotid stents may fail deployment
FDA (Devices) · 2026-06-17